ArticleHeart rhythm O22026
Left ventricular wall thickness on systolic-phase pulmonary vein CT as a marker for cardiac amyloidosis.
Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiac amyloidosis (CA) is under-recognized and frequently associated with atrial fibrillation (AF). Pulmonary vein computed tomography (CT) is routinely obtained by electrophysiologists for AF ablation planning, but its potential for identifying incidental features of CA, such as increased left ventricular (LV) wall thickness, remains unexplored. Objective: This study aimed to evaluate whether LV wall thickness measured on systolic-phase pulmonary vein CT can identify patients with CA. Methods: We retrospectively identified 160 patients who underwent systolic-phase pulmonary vein CT for AF ablation planning, including 80 patients with confirmed CA, and 80 age- and sex-matched controls. LV anteroseptal and inferoseptal wall thickness were measured using multiplanar reconstruction. Results: The mean age was 73 years, and 10% were female. Patients with CA had a significantly higher LV wall thickness than controls (mean septal thickness 22.3 ± 3.5 mm vs 14.9 ± 2.5 mm; Conclusion: Systolic-phase LV wall thickness measured on pulmonary vein CT is significantly increased in patients with CA and may serve as an early imaging prompt for further diagnostic evaluation. Routine assessment of LV thickness on AF ablation CTs could provide an opportunity for earlier detection and intervention for unrecognized CA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.